chr7-116795714-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000245.4(MET):​c.3858C>T​(p.Asp1286Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.432 in 1,613,762 control chromosomes in the GnomAD database, including 156,030 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.35 ( 11009 hom., cov: 31)
Exomes 𝑓: 0.44 ( 145021 hom. )

Consequence

MET
NM_000245.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:17

Conservation

PhyloP100: -2.04

Publications

50 publications found
Variant links:
Genes affected
MET (HGNC:7029): (MET proto-oncogene, receptor tyrosine kinase) This gene encodes a member of the receptor tyrosine kinase family of proteins and the product of the proto-oncogene MET. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that are linked via disulfide bonds to form the mature receptor. Further processing of the beta subunit results in the formation of the M10 peptide, which has been shown to reduce lung fibrosis. Binding of its ligand, hepatocyte growth factor, induces dimerization and activation of the receptor, which plays a role in cellular survival, embryogenesis, and cellular migration and invasion. Mutations in this gene are associated with papillary renal cell carcinoma, hepatocellular carcinoma, and various head and neck cancers. Amplification and overexpression of this gene are also associated with multiple human cancers. [provided by RefSeq, May 2016]
MET Gene-Disease associations (from GenCC):
  • hereditary papillary renal cell carcinoma
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • papillary renal cell carcinoma
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen
  • autosomal recessive nonsyndromic hearing loss 97
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • osteofibrous dysplasia
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • arthrogryposis, distal, IIa 11
    Inheritance: AD, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 7-116795714-C-T is Benign according to our data. Variant chr7-116795714-C-T is described in ClinVar as Benign. ClinVar VariationId is 93574.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.04 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.454 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000245.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MET
NM_000245.4
MANE Select
c.3858C>Tp.Asp1286Asp
synonymous
Exon 20 of 21NP_000236.2
MET
NM_001127500.3
c.3912C>Tp.Asp1304Asp
synonymous
Exon 20 of 21NP_001120972.1P08581-2
MET
NM_001324402.2
c.2568C>Tp.Asp856Asp
synonymous
Exon 19 of 20NP_001311331.1B4DLF5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MET
ENST00000397752.8
TSL:1 MANE Select
c.3858C>Tp.Asp1286Asp
synonymous
Exon 20 of 21ENSP00000380860.3P08581-1
MET
ENST00000318493.11
TSL:1
c.3912C>Tp.Asp1304Asp
synonymous
Exon 20 of 21ENSP00000317272.6P08581-2
MET
ENST00000436117.3
TSL:1
n.*1463C>T
non_coding_transcript_exon
Exon 19 of 20ENSP00000410980.2P08581-3

Frequencies

GnomAD3 genomes
AF:
0.348
AC:
52907
AN:
151856
Hom.:
11022
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.100
Gnomad AMI
AF:
0.305
Gnomad AMR
AF:
0.443
Gnomad ASJ
AF:
0.487
Gnomad EAS
AF:
0.469
Gnomad SAS
AF:
0.455
Gnomad FIN
AF:
0.382
Gnomad MID
AF:
0.430
Gnomad NFE
AF:
0.448
Gnomad OTH
AF:
0.389
GnomAD2 exomes
AF:
0.433
AC:
107988
AN:
249486
AF XY:
0.435
show subpopulations
Gnomad AFR exome
AF:
0.0896
Gnomad AMR exome
AF:
0.518
Gnomad ASJ exome
AF:
0.487
Gnomad EAS exome
AF:
0.460
Gnomad FIN exome
AF:
0.394
Gnomad NFE exome
AF:
0.444
Gnomad OTH exome
AF:
0.455
GnomAD4 exome
AF:
0.441
AC:
644758
AN:
1461788
Hom.:
145021
Cov.:
53
AF XY:
0.442
AC XY:
321615
AN XY:
727204
show subpopulations
African (AFR)
AF:
0.0870
AC:
2912
AN:
33478
American (AMR)
AF:
0.510
AC:
22802
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.490
AC:
12816
AN:
26132
East Asian (EAS)
AF:
0.490
AC:
19437
AN:
39698
South Asian (SAS)
AF:
0.452
AC:
39026
AN:
86254
European-Finnish (FIN)
AF:
0.399
AC:
21330
AN:
53420
Middle Eastern (MID)
AF:
0.427
AC:
2456
AN:
5756
European-Non Finnish (NFE)
AF:
0.447
AC:
497526
AN:
1111930
Other (OTH)
AF:
0.438
AC:
26453
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
23729
47458
71187
94916
118645
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14942
29884
44826
59768
74710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.348
AC:
52883
AN:
151974
Hom.:
11009
Cov.:
31
AF XY:
0.351
AC XY:
26035
AN XY:
74274
show subpopulations
African (AFR)
AF:
0.100
AC:
4154
AN:
41460
American (AMR)
AF:
0.443
AC:
6762
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.487
AC:
1689
AN:
3466
East Asian (EAS)
AF:
0.470
AC:
2424
AN:
5162
South Asian (SAS)
AF:
0.454
AC:
2186
AN:
4820
European-Finnish (FIN)
AF:
0.382
AC:
4026
AN:
10548
Middle Eastern (MID)
AF:
0.412
AC:
121
AN:
294
European-Non Finnish (NFE)
AF:
0.448
AC:
30431
AN:
67944
Other (OTH)
AF:
0.384
AC:
812
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1560
3120
4681
6241
7801
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
518
1036
1554
2072
2590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.419
Hom.:
23098
Bravo
AF:
0.343
Asia WGS
AF:
0.415
AC:
1442
AN:
3478
EpiCase
AF:
0.448
EpiControl
AF:
0.447

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not specified (7)
-
-
4
Papillary renal cell carcinoma type 1 (4)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
2
not provided (2)
-
-
1
Autosomal recessive nonsyndromic hearing loss 97 (1)
-
-
1
Renal cell carcinoma (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
0.050
DANN
Benign
0.42
PhyloP100
-2.0
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41736; hg19: chr7-116435768; COSMIC: COSV59255908; API